Page last updated: 2024-08-23

etoposide and Brain Damage, Chronic

etoposide has been researched along with Brain Damage, Chronic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartels, U; Bouffet, E; Greenberg, M; Halliday, W; Kamaly-Asl, ID; Kulkarni, AV; Lafay-Cousin, L; Mabbott, DJ; Tabori, U; Taylor, MD1
Estlin, EJ; Moulin, CJ; Pauly-Takacs, K1
Jereb, B; Macedoni-Luksic, M; Todorovski, L1
Allen, J; Atlas, MP; Dunkel, IJ; Fangusaro, JR; Finlay, JL; Gardner, S; Gonzalez-Gomez, I; Jubran, RF; Miller, D; Rosenblum, M1
Hagiwara, Y; Hayakawa, T; Kanayama, T; Miyawaki, Y; Nakagawa, H; Tokiyoshi, K; Tsuruzono, K; Yamada, M1

Trials

1 trial(s) available for etoposide and Brain Damage, Chronic

ArticleYear
Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Damage, Chronic; Brain Stem; Carboplatin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Etoposide; Humans; Infant; Infratentorial Neoplasms; Leucovorin; Mesna; Methotrexate; Neuroectodermal Tumors, Primitive; Peripheral Blood Stem Cell Transplantation; Remission Induction; Thiotepa; Transplantation, Autologous; Vincristine

2008

Other Studies

4 other study(ies) available for etoposide and Brain Damage, Chronic

ArticleYear
Use of ifosfamide, carboplatin, and etoposide chemotherapy in choroid plexus carcinoma.
    Journal of neurosurgery. Pediatrics, 2010, Volume: 5, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Damage, Chronic; Carboplatin; Child, Preschool; Choroid Plexus Neoplasms; Cognition Disorders; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Neoadjuvant Therapy; Postoperative Complications; Reoperation; Retrospective Studies

2010
SenseCam as a rehabilitation tool in a child with anterograde amnesia.
    Memory (Hove, England), 2011, Volume: 19, Issue:7

    Topics: Adolescent; Amnesia, Anterograde; Antineoplastic Combined Chemotherapy Protocols; Brain Damage, Chronic; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cues; Environmental Monitoring; Etoposide; Feasibility Studies; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Image Processing, Computer-Assisted; Male; Memory, Long-Term; Memory, Short-Term; Meningeal Neoplasms; Mental Recall; Microcomputers; Neuropsychological Tests; Photography; Radiation Injuries; Recognition, Psychology; Self-Help Devices

2011
Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.
    Pediatric hematology and oncology, 2003, Volume: 20, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Brain Damage, Chronic; Brain Neoplasms; Calcinosis; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disabled Children; Epilepsy; Etoposide; Female; Humans; Hydrocephalus; Infant; Intellectual Disability; Learning Disabilities; Lomustine; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Neoplasm Recurrence, Local; Prevalence; Procarbazine; Radiation Injuries; Slovenia; Survivors; Tomography, X-Ray Computed; Unemployment; Vincristine; Vision Disorders

2003
Myelin basic protein in the cerebrospinal fluid of patients with brain tumors.
    Neurosurgery, 1994, Volume: 34, Issue:5

    Topics: Adult; Aged; Astrocytoma; Biomarkers, Tumor; Brain Damage, Chronic; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Follow-Up Studies; Glioblastoma; Humans; Infusions, Intra-Arterial; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Myelin Basic Protein; Treatment Outcome

1994